Massive obstetric haemorrhage. Action guidelines of the Universitary Maternal Hospital La Paz;Hemorragia masiva obstétrica. Protocolo de actuación del Hospital Maternal Universitario La Paz

Actualizaciones en Anestesiologia y Reanimacion

Volumn 16, Issue 2, 2006, Pages 78-83

  Guasch, Emilia ^a,c   Viejo, A ^a   Martinez B ^a   Jimenez Yuste V ^a   Mateos, F ^a   Gonzalez A ^a,b   De La Rua, A ^a   Gilsanz, F ^a,b  

^a HOSPITAL INFANTIL LA PAZ   (Spain)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Obstetric anesthesia; Obstetric haemorrhage; Protocols

Indexed keywords

BLOOD CLOTTING FACTOR 9 CONCENTRATE; OCTAPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLOOD; BLOOD BANK; ERYTHROCYTE; FIBRINOGEN BLOOD LEVEL; HEALTH CARE ORGANIZATION; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; OBSTETRIC ANESTHESIA; OBSTETRIC HEMORRHAGE; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; UNITED KINGDOM; UNIVERSITY HOSPITAL;

EID: 33749325765     PISSN: 11320095     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Department of Health. Confidential enquiry into maternal and child health. Why mothers die 2000-2002. The sixth report of the confidential enquiries into maternal deaths in the UK. RCOG Press; 2004.
2. Pinder A, Dresner M. Massive obstetric haemorrhage. Curr Anesth Crit Care 2005; 16: 181-8.
3. Papp Z. Massive obstetric hemorrhage. J Perinat Med 2003; 31: 408-14.
4. Bonnar P. Massive obstetric haemorrhage. Clin Obstet Gynaecol 2000; 14: 1-18.
5. Santoso JT, Saunders BA, Grosshart K. Massive blood loss and transfusion in obstetrics and gynecology. Obstet Gynecol Survey 2005; 60: 827-37.
6. Scotish Obstetric Guidelines and audit project: the management of postpartum haemorrhage (Pilot edition). SPCERH Publication number 6.
7. Grounds RM. Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings. Crit Care 2005; 9 (Suppl 5): S29-S36.
8. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 94: 592-5.
9. Tucci MA, Makris M. Is recombinant fVIIa the magic bullet in the treatment of major bleeding? Br J Anaesth 2005; 94: 553-5.
10. Fries D, Innerhofer P, Reif C, Streif W, Klingler A, Schoberbergers W, et al. The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 2006; 102: 347-51.
11. De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006; 102: 1194-200.